KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.98

Cerebral Oximetry in Extremely Preterm Infants: 2-Year Follow-Up of the SafeBoosC-III Randomized Clinical Trial.

Marie Isabel Skov Rasmussen, Mathias L Hansen, Adelina Pellicer, Simon Hyttel-Sørensen, Ebru Ergenekon, Tomasz Szczapa, Cornelia Hagmann, Gunnar Naulaers, Jonathan Mintzer, Monica Fumagalli, Gabriel Dimitriou, Eugene Dempsey, Jakub Tkaczyk, Siv Fredly, Anne M Heuchan, Gerhard Pichler, Hans Fuchs, Saudamini Nesargi, Gitte H Hahn, Salvador Piris-Borregas, Jan Širc, Miguel Alsina-Casanova, Martin Stocker, Hilal Ozkan, Kosmas Sarafidis, Nicole J Kraus, Tanja Karen, Beata Rzepecka-Weglarz, Serife S Oguz, Liesbeth Thewissen, Luis Arruza, Asli C Memisoglu, Ruth Del Rio Florentino, Mariana Baserga, Pierre Maton, Juliane Schneider, M Isabel de Las Cuevas, Sofie Sommer Hedegaard, Pamela Zafra, Lars Bender, Sarah Farquharson, Agnieszka Ochoda-Mazur, Chantal Lecart, Afif El-Khuffash, Caitríona Ní Chathasaigh, Jan Miletin, Evangelia Papathoma, Zachary Vesoulis, Francesca Serrao, SafeBoosC-III Follow-Up Writing Group for the SafeBoosC-III Follow-Up Collaborator Group, Luc Cornette, Beril Yasa, Anja Klamer, Francisca Barcos-Munoz, Tatiana Boetti, Merih Cetinkaya, Mahmoud Montasser, Eleftheria Hatzidaki, Renata Bokiniec, Sylwia Marciniak, Lina Chalak, Shashidhar A Rao, Iwona Sadowska-Krawczenko, Itziar Serrano-Viñuales, Barbara Krolak-Olejnik, Anne Mette Plomgaard, Bo Mølholm Hansen, Markus Harboe Olsen, Christian Gluud, Janus C Jakobsen, Gorm Greisen

JAMA Pediatr 180(6) 619-627

PMID42008246
PMCIDPMC13097032
DOI10.1001/jamapediatrics.2026.1066
发表日期2026-04-20
入排依据:未发现恶性肿瘤人群证据。
疑似漏检:论文标题/摘要/图注含 OS/PFS/DFS/EFS/survival 等生存终点信号,但当前未得到 KM 提取结果。 已检查 1 张 PMC Figure,均未识别为 KM 图:Figure.:非 KM 图。
摘要

摘要

IMPORTANCE: Cerebral oximetry monitoring in the first 72 hours after birth has not been shown to reduce death or severe brain injury at 36 weeks' postmenstrual age in extremely preterm infants. The long-term effects remain uncertain. OBJECTIVE: To determine whether treatment guided by cerebral oximetry monitoring during the first 72 hours after birth reduces the risk of death or longer-term neurodevelopmental outcomes at 2 years' corrected age, compared with usual care. DESIGN, SETTING, AND PARTICIPANTS: In the phase 3 Safeguarding the Brain of Our Smallest Children (SafeBoosC-III) randomized clinical trial, we compared treatment guided by cerebral oximetry monitoring with usual care for the first 72 hours after birth. Seventy sites across 17 countries randomized 1601 infants within 6 hours of birth. Infants from 56 sites participated in this follow-up. Blinded assessors evaluated outcomes using a predefined 3-tier data model combining formal clinical assessments, parental questionnaires, and informal assessments. Data were analyzed from October to December 2024. INTERVENTIONS: Treatment guided by cerebral oximetry monitoring for the first 72 hours after birth vs usual care. MAIN OUTCOMES AND MEASURES: The coprimary outcomes were as follows: (1) death or moderate or severe neurodevelopmental disability and (2) Bayley cognitive composite score, both assessed at approximately 2 years' corrected age. RESULTS: A total of 1438 infants (mean [SD] age, 26.0 [1.3] weeks; 758 male [52.7%]) participated in this follow-up study. Participants were followed up from October 2021 to October 2024. Death or moderate or severe neurodevelopmental disability occurred in 292 of 620 infants (47.1%) in the cerebral oximetry group compared with 321 of 669 infants (48.0%) in the usual-care group (relative risk with cerebral oximetry, 0.96; 97.5% CI, 0.85-1.07; P = .45). The mean (SD) Bayley cognitive score was 92.8 (17.0) in the cerebral oximetry group compared with 93.2 (17.3) in the usual-care group (mean difference with cerebral oximetry, -0.14; 97.5% CI, -3.24 to 2.96; P = .92). CONCLUSIONS AND RELEVANCE: In extremely preterm infants, treatment guided by cerebral oximetry monitoring compared with usual care for the first 72 hours after birth did not result in a lower incidence of death or moderate or severe neurodevelopmental disability nor higher Bayley cognitive scores at 2 years' corrected age. The routine use of cerebral oximetry monitoring during the first 72 hours after birth in extremely preterm infants to reduce neurodevelopmental disability was not supported by this trial. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT05134116.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(1,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Figure.Flowchart Depicting Randomization, 36-Week Follow-Up, and 2-Year Follow-Up
非 KM Figure